Dorsavi Ltd Cash Flow Conversion Efficiency
Dorsavi Ltd cash flow conversion efficiency. Based on the latest financial reports, Dorsavi Ltd (DVL) has a cash flow conversion efficiency ratio of -0.251x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-710.48K ≈ $-502.71K USD) by net assets (AU$2.84 Million ≈ $2.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Dorsavi Ltd (2013–2025)
Cash flow conversion efficiency of Dorsavi Ltd from 2013 to 2025. This chart illustrates how Dorsavi Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Dorsavi Ltd share price for real-time trading data and today's change.
Dorsavi Ltd Cash Flow Conversion Ratio Explained
Dorsavi Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Dorsavi Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dorsavi Ltd ranked by their cash flow conversion efficiency. Also see DVL market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jasper Therapeutics Inc
NASDAQ:JSPR
|
-4.897x |
|
Deltamac Taiwan Co Ltd
TWO:6144
|
0.006x |
|
Century Casinos Inc
NASDAQ:CNTY
|
-0.241x |
|
Fuji Finance Indonesia Tbk PT
JK:FUJI
|
0.122x |
|
Shradha Infraprojects Limited
NSE:SHRADHA
|
-0.075x |
|
ATP 30 Public Company Limited
BK:ATP30
|
0.090x |
|
Microba Life Sciences Ltd
AU:MAP
|
-0.184x |
|
Saga plc
LSE:SAGA
|
0.721x |
Annual Cash Flow Conversion Efficiency for Dorsavi Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of Dorsavi Ltd from 2013 to 2025. Review Dorsavi Ltd (DVL) financial flexibility to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$2.84 Million ≈ $2.01 Million |
AU$-956.83K ≈ $-677.02K |
-0.337x | +42.53% |
| 2024-06-30 | AU$1.02 Million ≈ $724.09K |
AU$-600.90K ≈ $-425.17K |
-0.587x | -1.89% |
| 2023-06-30 | AU$1.68 Million ≈ $1.19 Million |
AU$-967.41K ≈ $-684.50K |
-0.576x | +67.34% |
| 2022-06-30 | AU$1.22 Million ≈ $863.69K |
AU$-2.15 Million ≈ $-1.52 Million |
-1.765x | -92.49% |
| 2021-06-30 | AU$2.48 Million ≈ $1.75 Million |
AU$-2.27 Million ≈ $-1.61 Million |
-0.917x | +80.69% |
| 2020-06-30 | AU$459.03K ≈ $324.79K |
AU$-2.18 Million ≈ $-1.54 Million |
-4.748x | -1493.17% |
| 2019-06-30 | AU$6.99 Million ≈ $4.95 Million |
AU$-2.08 Million ≈ $-1.47 Million |
-0.298x | -8.06% |
| 2018-06-30 | AU$9.42 Million ≈ $6.66 Million |
AU$-2.60 Million ≈ $-1.84 Million |
-0.276x | -6.89% |
| 2017-06-30 | AU$13.13 Million ≈ $9.29 Million |
AU$-3.39 Million ≈ $-2.40 Million |
-0.258x | +62.73% |
| 2016-06-30 | AU$8.59 Million ≈ $6.08 Million |
AU$-5.95 Million ≈ $-4.21 Million |
-0.692x | +41.94% |
| 2015-06-30 | AU$6.62 Million ≈ $4.68 Million |
AU$-7.89 Million ≈ $-5.58 Million |
-1.192x | -448.46% |
| 2014-06-30 | AU$14.62 Million ≈ $10.34 Million |
AU$-3.18 Million ≈ $-2.25 Million |
-0.217x | -212.65% |
| 2013-06-30 | AU$18.49 Million ≈ $13.08 Million |
AU$-1.29 Million ≈ $-909.93K |
-0.070x | -- |
About Dorsavi Ltd
dorsaVi Ltd engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States. It operates through two segments: Clinical and Workplace. The company provides ViMove+, a clinical and sports solutions; ViSafe, a wearable sensor technology that analyzes how workforce moves and reviews and pinpoints unsafe work practices that leads to workplace injury; an… Read more